首页> 外文期刊>World Journal of Surgical Oncology >Number of evaluated lymph nodes and positive lymph nodes, lymph node ratio, and log odds evaluation in early-stage pancreatic ductal adenocarcinoma: numerology or valid indicators of patient outcome?
【24h】

Number of evaluated lymph nodes and positive lymph nodes, lymph node ratio, and log odds evaluation in early-stage pancreatic ductal adenocarcinoma: numerology or valid indicators of patient outcome?

机译:早期胰腺导管腺癌的评估淋巴结和阳性淋巴结数目,淋巴结比率和对数比值评估:命理学或患者预后的有效指标?

获取原文
           

摘要

Background We evaluated the prognostic significance and universal validity of the total number of evaluated lymph nodes (ELN), number of positive lymph nodes (PLN), lymph node ratio (LNR), and log odds of positive lymph nodes (LODDS) in a relatively large and homogenous cohort of surgically treated pancreatic ductal adenocarcinoma (PDAC) patients. Methods Prospectively accrued data were retrospectively analyzed for 282 PDAC patients who had pancreaticoduodenectomy (PD) at our institution. Long-term survival was analyzed according to the ELN, PLN, LNR, and LODDS. Results Of these patients, 168 patients (59.5?%) had LN metastasis (N1). Mean ELN and PLN were 13.5 and 1.6, respectively. LN positivity correlated with a greater number of evaluated lymph nodes; positive lymph nodes were identified in 61.4?% of the patients with ELN?≥?13 compared with 44.9?% of the patients with ELN?Conclusions Our data confirms that lymph node positivity strongly reflects PDAC biology and thus patient outcome. While a higher number of evaluated lymph nodes may provide a more accurate nodal staging, it does not have any prognostic value among N1 patients. Similarly, PLN, LNR, and LODDS had limited prognostic relevance.
机译:背景我们评估了相对评估的淋巴结总数(ELN),阳性淋巴结数目(PLN),淋巴结比率(LNR)和阳性淋巴结对数比对数(LODDS)的预后意义和普遍有效性手术治疗的胰腺导管腺癌(PDAC)患者的大型且同质队列。方法对我院282例行胰十二指肠切除术(PD)的PDAC患者的前瞻性数据进行回顾性分析。根据ELN,PLN,LNR和LODDS分析长期存活率。结果在这些患者中,有168例(59.5%)发生了LN转移(N1)。平均ELN和PLN分别为13.5和1.6。 LN阳性与更多的评估淋巴结相关;阳性淋巴结的检出率为61.4%,而ELN≥13的检出率为44.9%。结论我们的数据证实淋巴结阳性强烈反映了PDAC生物学,因此反映了患者的预后。虽然更多的淋巴结评估可以提供更准确的淋巴结分期,但在N1例患者中没有任何预后价值。同样,PLN,LNR和LODDS的预后相关性有限。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号